Mark Fidock

2.1k total citations · 1 hit paper
32 papers, 1.6k citations indexed

About

Mark Fidock is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, Mark Fidock has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 8 papers in Immunology. Recurrent topics in Mark Fidock's work include Receptor Mechanisms and Signaling (11 papers), Neuropeptides and Animal Physiology (5 papers) and Asthma and respiratory diseases (5 papers). Mark Fidock is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Neuropeptides and Animal Physiology (5 papers) and Asthma and respiratory diseases (5 papers). Mark Fidock collaborates with scholars based in United Kingdom, United States and Sweden. Mark Fidock's co-authors include Nicola Robas, Emma J. Mead, Steven A. Trim, Janet J. Maguire, Rhoda E. Kuc, Anthony P. Davenport, Clare Gardner, Beate Peter, Ronald P. Gladue and Stephen Jenkinson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Mark Fidock

32 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of a five-dimensional framework on R&D productivity at AstraZeneca

2018 271 citations Paul Morgan, Dean G. Brown et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Fidock United Kingdom	20	807	358	329	323	129	32	1.6k
Norbert Kociok Germany	27	1.4k 1.7×	312 0.9×	236 0.7×	206 0.6×	69 0.5×	90	3.3k
John C. Anthes United States	22	1.3k 1.6×	493 1.4×	282 0.9×	638 2.0×	55 0.4×	62	2.3k
Zhongji Liao United States	14	656 0.8×	245 0.7×	157 0.5×	232 0.7×	86 0.7×	21	1.6k
Louise Larose Canada	29	1.4k 1.7×	327 0.9×	275 0.8×	203 0.6×	113 0.9×	74	2.3k
Keri Tate United States	13	676 0.8×	435 1.2×	253 0.8×	462 1.4×	102 0.8×	19	1.7k
Jessica Zhu United States	16	852 1.1×	354 1.0×	326 1.0×	274 0.8×	63 0.5×	22	2.0k
Joseph A. Erhardt United States	25	1.3k 1.6×	346 1.0×	457 1.4×	404 1.3×	204 1.6×	32	2.6k
Helge Boman Norway	26	1.1k 1.3×	173 0.5×	208 0.6×	214 0.7×	77 0.6×	73	2.1k
Sylvie Cazaubon France	22	1.2k 1.4×	296 0.8×	261 0.8×	299 0.9×	135 1.0×	35	2.3k
Mads Kjølby Denmark	21	660 0.8×	317 0.9×	236 0.7×	248 0.8×	283 2.2×	46	1.8k

Countries citing papers authored by Mark Fidock

Since Specialization

Citations

This map shows the geographic impact of Mark Fidock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Fidock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Fidock more than expected).

Fields of papers citing papers by Mark Fidock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Fidock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Fidock. The network helps show where Mark Fidock may publish in the future.

Co-authorship network of co-authors of Mark Fidock

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Fidock. A scholar is included among the top collaborators of Mark Fidock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Fidock. Mark Fidock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rutten, Bart P. F., Simon Young, Magdalena Rhedin, et al.. (2021). Eosinophil-derived neurotoxin: A biologically and analytically attractive asthma biomarker. PLoS ONE. 16(2). e0246627–e0246627. 27 indexed citations

Rutten, Bart P. F., Simon Young, Mark Fidock, et al.. (2021). The commutability of enzyme linked immunosorbent assays for the quantification of serum eosinophil-derived neurotoxin (EDN). Journal of Immunological Methods. 500. 113181–113181. 2 indexed citations

Clausen, Maryam, Rebecca Halpin, Kang Cai, et al.. (2021). A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce. Scientific Reports. 11(1). 12676–12676. 1 indexed citations

Morgan, Paul, Dean G. Brown, Simon Lennard, et al.. (2018). Impact of a five-dimensional framework on R&D productivity at AstraZeneca. Nature Reviews Drug Discovery. 17(3). 167–181. 271 indexed citations breakdown →

Aeinehband, Shahin, Philip Brenner, Sara Ståhl, et al.. (2015). Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms. Brain Behavior and Immunity. 51. 47–55. 62 indexed citations

Murray, Megan Y., Timothy P. Birkland, Jonathan D. Howe, et al.. (2013). Macrophage Migration and Invasion Is Regulated by MMP10 Expression. PLoS ONE. 8(5). e63555–e63555. 79 indexed citations

Colman, Peter, Frances Burden, Carl Laxton, et al.. (2012). Therapy with TLR7 Agonists Induces Lymphopenia: Correlating Pharmacology to Mechanism in a Mouse Model. Journal of Clinical Immunology. 32(5). 1082–1092. 20 indexed citations

Fidock, Mark, Carl Laxton, Peter Colman, et al.. (2011). The Innate Immune Response, Clinical Outcomes, and Ex Vivo HCV Antiviral Efficacy of a TLR7 Agonist (PF-4878691). Clinical Pharmacology & Therapeutics. 89(6). 821–829. 64 indexed citations

Wijeyesekera, Anisha, Philip A. Clarke, Magda Bictash, et al.. (2011). Quantitative UPLC-MS/MS analysis of the gut microbial co-metabolites phenylacetylglutamine, 4-cresyl sulphate and hippurate in human urine: INTERMAP Study. Analytical Methods. 4(1). 65–72. 28 indexed citations

10.

Hewson, Christopher A., et al.. (2011). A differential role for ceramide kinase in antigen/FcɛRI-mediated mast cell activation and function. Clinical & Experimental Allergy. 41(3). 389–398. 4 indexed citations

11.

Tomlinson, Matthew L., Pingping Guan, Richard J. Morris, et al.. (2009). A Chemical Genomic Approach Identifies Matrix Metalloproteinases as Playing an Essential and Specific Role in Xenopus Melanophore Migration. Chemistry & Biology. 16(1). 93–104. 42 indexed citations

12.

Ulrich, Kristina, Roddy Walsh, Mark Fidock, et al.. (2008). Anti-inflammatory modulation of chronic airway inflammation in the murine house dust mite model. Pulmonary Pharmacology & Therapeutics. 21(4). 637–647. 41 indexed citations

13.

Fidock, Mark, et al.. (2007). Allosteric effects of antagonists on signalling by the chemokine receptor CCR5. Biochemical Pharmacology. 74(6). 891–897. 13 indexed citations

14.

Milasta, Sandra, John D. Pediani, Steven A. Trim, et al.. (2005). Interactions between the Mas-Related Receptors MrgD and MrgE Alter Signalling and Trafficking of MrgD. Molecular Pharmacology. 69(2). 479–491. 57 indexed citations

15.

Singh, Gurminder, Janet J. Maguire, Rhoda E. Kuc, Mark Fidock, & Anthony P. Davenport. (2004). Identification and cellular localisation of NPW1 (GPR7) receptors for the novel neuropeptide W-23 by [125I]-NPW radioligand binding and immunocytochemistry. Brain Research. 1017(1-2). 222–226. 29 indexed citations

16.

Ramsay, Douglas, Ian Carr, John D. Pediani, et al.. (2004). High-Affinity Interactions between Human α1A-Adrenoceptor C-Terminal Splice Variants Produce Homo- and Heterodimers but Do Not Generate the α1L-Adrenoceptor. Molecular Pharmacology. 66(2). 228–239. 54 indexed citations

17.

Robas, Nicola, Emma J. Mead, & Mark Fidock. (2003). MrgX2 Is a High Potency Cortistatin Receptor Expressed in Dorsal Root Ganglion. Journal of Biological Chemistry. 278(45). 44400–44404. 203 indexed citations

18.

Fidock, Mark, et al.. (2002). Isolation and differential tissue distribution of two human cDNAs encoding PDE1 splice variants. Cellular Signalling. 14(1). 53–60. 26 indexed citations

19.

Jenkinson, Stephen, Ronald P. Gladue, Shane Foo, et al.. (2002). IDENTIFICATION OF A HISTAMINE H₄RECEPTOR ON HUMAN EOSINOPHILS—ROLE IN EOSINOPHIL CHEMOTAXIS. Journal of Receptors and Signal Transduction. 22(1-4). 431–448. 159 indexed citations

20.

Squires, Paul E., et al.. (1996). Regulation of Intracellular Ca²⁺ in Response to Muscarinic and Glutamate Receptor Agonists During the Differentiation of NTERA2 Human Embryonal Carcinoma Cells into Neurons. European Journal of Neuroscience. 8(4). 783–793. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact